3.1%) with pembrolizumab; however, OS improvements did not reach statistical significance ( Rudin et al., 2020 ).
also in 111,027 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.